Amandine Alard

2.3k total citations · 1 hit paper
13 papers, 1.6k citations indexed

About

Amandine Alard is a scholar working on Molecular Biology, Reproductive Medicine and Surgery. According to data from OpenAlex, Amandine Alard has authored 13 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 2 papers in Reproductive Medicine and 1 paper in Surgery. Recurrent topics in Amandine Alard's work include RNA and protein synthesis mechanisms (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and RNA modifications and cancer (4 papers). Amandine Alard is often cited by papers focused on RNA and protein synthesis mechanisms (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers) and RNA modifications and cancer (4 papers). Amandine Alard collaborates with scholars based in United States and France. Amandine Alard's co-authors include Robert J. Schneider, Sandra Demaria, Julie M. Diamond, Silvia C. Formenti, Claire Vanpouille‐Box, Molykutty J. Aryankalayil, C. Norman Coleman, Yasmeen Sarfraz, Giorgio Inghirami and Amanda Ernlund and has published in prestigious journals such as Nature Communications, Genes & Development and The EMBO Journal.

In The Last Decade

Amandine Alard

13 papers receiving 1.6k citations

Hit Papers

DNA exonuclease Trex1 regulates radiotherapy-induced tumo... 2017 2026 2020 2023 2017 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity
    2017 1.2k citations Claire Vanpouille‐Box, Amandine Alard et al. Nature Communications profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amandine Alard United States 10 851 724 576 315 169 13 1.6k
Molykutty J. Aryankalayil United States 14 983 1.2× 810 1.1× 520 0.9× 449 1.4× 287 1.7× 30 1.8k
Dario Sangiolo Italy 25 1.4k 1.6× 1.1k 1.5× 549 1.0× 442 1.4× 200 1.2× 76 2.2k
Karsten A. Pilones United States 16 1.4k 1.7× 1.1k 1.6× 449 0.8× 342 1.1× 236 1.4× 41 2.0k
Hampartsoum B. Barsoumian United States 25 937 1.1× 709 1.0× 426 0.7× 425 1.3× 258 1.5× 57 1.6k
Jesse M. Zaretsky United States 8 1.5k 1.8× 1.3k 1.8× 518 0.9× 278 0.9× 183 1.1× 16 2.1k
Alex Chehrazi‐Raffle United States 11 869 1.0× 461 0.6× 374 0.6× 331 1.1× 171 1.0× 64 1.3k
Nikolina Bąbała Netherlands 9 1.0k 1.2× 1.3k 1.7× 509 0.9× 194 0.6× 183 1.1× 11 1.8k
Anna Wilkins United Kingdom 16 640 0.8× 430 0.6× 340 0.6× 400 1.3× 140 0.8× 39 1.3k
Colm R. Duffy United States 4 1.6k 1.9× 1.1k 1.6× 514 0.9× 394 1.3× 209 1.2× 11 2.3k
Davis Y. Torrejon United States 10 1.4k 1.6× 924 1.3× 487 0.8× 463 1.5× 230 1.4× 16 2.0k

Countries citing papers authored by Amandine Alard

Since Specialization
Citations

This map shows the geographic impact of Amandine Alard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amandine Alard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amandine Alard more than expected).

Fields of papers citing papers by Amandine Alard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amandine Alard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amandine Alard. The network helps show where Amandine Alard may publish in the future.

Co-authorship network of co-authors of Amandine Alard

This figure shows the co-authorship network connecting the top 25 collaborators of Amandine Alard. A scholar is included among the top collaborators of Amandine Alard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amandine Alard. Amandine Alard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Alard, Amandine, Olga Katsara, Columba de la Parra, et al.. (2023). Breast cancer cell mesenchymal transition and metastasis directed by DAP5/eIF3d-mediated selective mRNA translation. Cell Reports. 42(6). 112646–112646. 24 indexed citations
2.
Alard, Amandine, David C. Muller, Stéphanie Cassant‐Sourdy, et al.. (2021). Phosphorylation of the MNK1 substrate eIF4E is not required for response to acute pancreatitis. Pancreatology. 21(4). 677–681. 2 indexed citations
3.
Martino, Mara De, Julie M. Diamond, Amandine Alard, et al.. (2020). Activin A Promotes Regulatory T-cell–Mediated Immunosuppression in Irradiated Breast Cancer. Cancer Immunology Research. 9(1). 89–102. 42 indexed citations
4.
Alard, Amandine, Bertrand Fabre, Christine Jean, et al.. (2019). Differential Regulation of the Three Eukaryotic mRNA Translation Initiation Factor (eIF) 4Gs by the Proteasome. Frontiers in Genetics. 10. 254–254. 11 indexed citations
5.
Parra, Columba de la, Amanda Ernlund, Amandine Alard, et al.. (2018). A widespread alternate form of cap-dependent mRNA translation initiation. Nature Communications. 9(1). 3068–3068. 120 indexed citations
6.
Vanpouille‐Box, Claire, Amandine Alard, Molykutty J. Aryankalayil, et al.. (2017). DNA exonuclease Trex1 regulates radiotherapy-induced tumour immunogenicity. Nature Communications. 8(1). 15618–15618. 1234 indexed citations breakdown →
7.
Ernlund, Amanda, Sofia Bakogianni, Amandine Alard, et al.. (2017). Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming. Genes & Development. 31(22). 2235–2249. 38 indexed citations
8.
Musa, Fernanda, Amandine Alard, Gizelka David‐West, et al.. (2016). Dual mTORC1/2 Inhibition as a Novel Strategy for the Resensitization and Treatment of Platinum-Resistant Ovarian Cancer. Molecular Cancer Therapeutics. 15(7). 1557–1567. 43 indexed citations
9.
Alard, Amandine, Fernanda Musa, & Robert J. Schneider. (2015). Abstract 2262: Evidence that the translational initiation factor DAP5 plays a critical role in breast cancer metastasis. Cancer Research. 75(15_Supplement). 2262–2262. 1 indexed citations
10.
Musa, Fernanda, Amandine Alard, Gizelka David‐West, et al.. (2014). Abstract 4525: mTOR complex inhibition as a novel therapeutic strategy in high-grade papillary serous ovarian cancer. Cancer Research. 74(19_Supplement). 4525–4525. 1 indexed citations
11.
Muller, David C., Amandine Alard, Robert J. Schneider, et al.. (2013). 4E-BP restrains eIF4E phosphorylation. PubMed. 1(2). e25819–e25819. 25 indexed citations
12.
Alard, Amandine, Bertrand Fabre, Rodica Anesia, et al.. (2009). NAD(P)H Quinone-Oxydoreductase 1 Protects Eukaryotic Translation Initiation Factor 4GI from Degradation by the Proteasome. Molecular and Cellular Biology. 30(4). 1097–1105. 30 indexed citations
13.
Azar, Rania, Amandine Alard, Christiane Susini, Corinne Bousquet, & Stéphane Pyronnet. (2009). 4E‐BP1 is a target of Smad4 essential for TGFβ‐mediated inhibition of cell proliferation. The EMBO Journal. 28(22). 3514–3522. 45 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Molykutty J. Aryankalayil Breakdown of academic impact, for papers by Dario Sangiolo Breakdown of academic impact, for papers by Karsten A. Pilones Breakdown of academic impact, for papers by Hampartsoum B. Barsoumian Breakdown of academic impact, for papers by Jesse M. Zaretsky Breakdown of academic impact, for papers by Alex Chehrazi‐Raffle Breakdown of academic impact, for papers by Nikolina Bąbała Breakdown of academic impact, for papers by Anna Wilkins Breakdown of academic impact, for papers by Colm R. Duffy Breakdown of academic impact, for papers by Davis Y. Torrejon
Rankless by CCL
2026